ASTELLAS PHARMA INC (ALPMF:OTCMKTS)
$12.85 -0.46 (-3.456%)
Analysed ASTELLAS PHARMA INC (ALPMF:OTCMKTS) News Sources
Astellas taps AI to reshape clinical programs as rising stars emerge
12-06-2026
pharmavoice.com
Astellas Pharma (TSE:4503) Stock Valuation After KRAS Trial Progress And AI Overhaul
13-06-2026
yahoo.com
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?
22-06-2026
yahoo.com
Is Astellas Pharma (ALPMY) Stock Undervalued Right Now?
22-06-2026
yahoo.com
Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
23-06-2026
yahoo.com
Sector Update: Healthcare Stocks Advance in Afternoon Trading
23-06-2026
yahoo.com
Sangamo holds a bankruptcy sale; VCs back a China-linked Beam competitor
24-06-2026
biopharmadive.com
U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
10-07-2026
yahoo.com
Pfizer Poised for Mixed Second Quarter, RBC Says
10-07-2026
yahoo.com
Pfizer (PFE) Announces FDA Approval of PADCEV plus Keytruda in MIBC
15-07-2026
yahoo.com
What is the current price of ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The current price of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is $12.85.
ASTELLAS PHARMA INC (ALPMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) since the previous trading day is $-0.46.
ASTELLAS PHARMA INC (ALPMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) since the previous trading day is -3.456%.
What is the most recent average sentiment score for ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The most recent average sentiment score for ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is 59 out of 100.
What is the most recent average sentiment for ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The most recent sentiment for ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is .
SEC-8K** Filing Available For ASTELLAS PHARMA INC (ALPMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.